Anjalee Khemlani

Walgreens is launching new services and consolidating specialty services to compete in the pharmacy benefits management (PBM) space.

AstraZeneca's ( AZN ) stock is up following its latest earnings report Thursday after the company reported $12.7 billion in revenue, beating consensus estimates of $11.8 billion in the first quarter of 2024.

· Just a few short years after coming to market, the latest GLP-1 drugs are showing versatility in battling diseases related to diabetes

Eli Lilly ( ) missed Wall Street consensus estimates on Mounjaro sales for the first quarter of the year, but its GLP-1 products, including Zepbound, still contributed to 26% sales growth year over year in the quarter.

Eli Lilly missed on total sales in the first quarter, but its GLP-1 drugs helped boost sales by 26% over those in Q1 2023.

Updated · Walmart ( WMT ) announced it is closing down its healthcare business Tuesday.

GE HealthCare Technologies' ( GEHC ) shares experienced a sharp decline in Tuesday's afternoon trading session, as the company's first quarterly report since its 2023 spinoff from General Electric fell short of revenue estimates. The company saw revenue drop 1% year-over-year, fueling a sell-off among investors.

CVS ( ) disappointed Wall Street Wednesday by missing revenue estimates and revising down its 2024 guidance, and expects to raise insurance plan prices in the coming year as it adjusts for Medicare reimbursement cuts.

CVS warns it could cede Medicare Advantage market share as reimbursement rates pressure the company.

Pfizer ( PFE ) beat on earnings in the first quarter of 2024, giving its stock a much-needed 7% boost Wednesday.